Amicus Therapeutics Inc. buy StockNews.com
Start price
16.11.24
/
50%
€9.20
Target price
16.11.25
-
Performance (%)
-16.30%
Price
07.11.25
€7.65
This prediction will end soon
Summary
This prediction is currently active. The prediction for Amicus Therapeutics Inc. disappoints with a performance of -16.30%. This prediction currently runs until 16.11.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | -3.165% | -3.165% |
| iShares Core DAX® | -0.917% | -3.612% |
| iShares Nasdaq 100 | -3.301% | -0.193% |
| iShares Nikkei 225® | -4.194% | 3.000% |
| iShares S&P 500 | -1.866% | -0.116% |
Comments by StockNews_com for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.45
26.10.25
26.10.25
-
26.10.26
26.10.26
2.68%
07.11.25
07.11.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.70
11.03.23
11.03.23
-
11.03.24
11.03.24
2.80%
12.03.24
12.03.24